Profil
Michael Broxson is currently a Director at Molecular Templates OpCo, Inc. and a Vice President, Head-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. He was previously the Chief Executive Officer at Q32 Bio, Inc. and a Director at Molecular Templates, Inc. Broxson received an undergraduate degree from Tulane University (Louisiana) and an MBA degree from The University of Chicago Booth School of Business.
Postes actifs de Michael Broxson
| Sociétés | Poste | Début |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur Technique/Scientifique/R&D | - |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Broxson
| Sociétés | Poste | Fin |
|---|---|---|
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Directeur Général | 20/09/2022 |
| MOLECULAR TEMPLATES, INC. | Directeur/Membre du Conseil | - |
Formation de Michael Broxson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Tulane University (Louisiana)
Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
















